AI misses 14% of invasive breast cancers on mammography, with luminal cancers and dense tissue posing significant challenges.
Key Details
- 1Study analyzed 1,097 breast cancers from 1,082 women using Lunit Insight MMG AI between 2014–2020.
- 2AI missed 154 cancers (14%), often in younger women with smaller (<2 cm), lower-grade tumors and dense breasts.
- 3Missed cancers were more likely luminal subtype (false-negative rate 17.2%), compared to HER2-enriched (9%) and triple-negative (14.5%).
- 4Major reasons for AI misses included dense breast tissue (n=56), nonmammary zone location (n=22), architectural distortion (n=12), and amorphous calcifications (n=5).
- 561.7% of AI-missed cancers were deemed 'actionable' on further review by radiologists.
Why It Matters
Understanding which cancer features are often overlooked by AI tools enables radiologists to better interpret AI results, reducing missed diagnoses. These insights highlight the continued importance of human expertise in mammography, especially for high-risk groups like women with dense breast tissue.
Source
AuntMinnie
Related News
•Radiology Business
Framework Assesses Real-World Financial Impact of Radiology AI Adoption
A new analysis presents a financial calculator for objectively assessing the return on investment (ROI) of implementing radiology AI solutions.
•Radiology Business
AI Technique Unveils Previously Hidden MS Gray Matter Lesions on MRI
Researchers developed an AI-enhanced method to detect previously invisible gray matter lesions in multiple sclerosis using MRI.
•Radiology Business
Majority of Patients Want Disclosure When AI Used in Imaging
A new survey finds that nearly all patients want to be informed when AI is utilized in medical imaging interpretation.